Home Top News and Stories Business News Headlines Biocon Rating: Hold – Vaccines to complement biosimilar portfolio

Biocon Rating: Hold – Vaccines to complement biosimilar portfolio

0
   

Biocon Rating: Hold – Vaccines to complement biosimilar portfolio

Deal with SILS could add NPV of `21/share to TP; better biosimilar execution remains key; ‘Hold’ retained

   

Follow us on Instagram

[instagram-feed]